|
⚲
|
| Keyboard |
| Varki Paul
✚
|
|
|---|---|
| CIK # | 0001677896 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001677896] | |
| 4 | [0001677896] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Varki Paul | |
| Avalo Therapeutics Inc | |
| Zyla Life Sciences |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 80,000 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-12-10 | Tax withheld | 1,016 | $4.10 | 4,166 |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2025-01-28 | Grant | 100,000 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2024-06-24 | Grant | 150,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock
|
2017-07-03 | Sell | 806 | $2.35 | 1,894 |
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2017-06-08 | Grant | 50,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock
|
2017-04-03 | Sell | 806 | $5.05 | 4,070 |
|
Zyla Life Sciences EGLT
Common Stock
|
2017-01-03 | Sell | 806 | $7.75 | 6,246 |
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2016-12-06 | Grant | 50,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock
|
2016-10-03 | Sell | 806 | $7.56 | 6,093 |